In late March, we decided to cancel all committee meetings and not publish any draft or final guidelines until further notice (except for guidance that is therapeutically critical or focused on COVID-19-related issues – see the link in the yellow banner at the top of the page). We are continuing with work where we can, however the consultation for this guideline will be delayed. We will provide further information on the revised timeline as soon as possible.
 
Status Schedule affected by COVID-19
Developed As CG

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
18 May 2020 Schedule affected by COVID-19. In late March, we decided to cancel all committee meetings and not publish any draft or final guidelines until further notice (except for guidance that is therapeutically critical or focused on COVID-19-related issues – see the link in the yellow banner at the top of the page). We are continuing with work where we can, however the consultation for this guideline will be delayed. We will provide further information on the revised timeline as soon as possible.
17 May 2019 Committee list updated
16 April 2019 Declaration of interests
01 February 2019 Committee meeting
15 January 2019 Scope published
24 September 2018 - 22 October 2018 Draft scope consultation
13 September 2018 Stakeholder list updated
29 August 2018 Scoping workshop: London
04 May 2018 - 18 May 2018 Committee chair recruitment

For further information on the guideline development process, please read how we develop NICE guidelines